America Great Health (AAGH) EBITDA (2014 - 2026)

America Great Health has reported EBITDA for 13 years, with the latest figure at -$73775.0 in Q1 2026.

• On a quarterly basis, EBITDA rose 13.53% year-over-year to -$73775.0 in Q1 2026; TTM through Mar 2026 was -$382177.0, a 45.12% increase from a year earlier, with the FY2025 full-year figure at -$382935.0, up 51.08% from the prior year.
• EBITDA was -$73775.0 for Q1 2026 at America Great Health, up from -$198775.0 in the prior quarter.
• The five-year high for EBITDA was -$3384.0 in Q3 2025, with the low at -$2.0 million in Q2 2022.
• Average EBITDA over 5 years is -$271576.7, with a median of -$120514.0 recorded in 2024.
• The sharpest annual moves came in 2022 and 2025: EBITDA tumbled 1275.42% in 2022, then jumped 95.22% in 2025.
• Over 5 years, EBITDA stood at -$95107.0 in 2022, then plunged by 61.78% to -$153867.0 in 2023, then rose by 21.68% to -$120514.0 in 2024, then plunged by 64.94% to -$198775.0 in 2025, then soared by 62.89% to -$73775.0 in 2026.
• The last three EBITDA figures came in at -$73775.0 (Q1 2026), -$198775.0 (Q4 2025), and -$3384.0 (Q3 2025), per Business Quant data.